United States of America based
Bioxcel Corporation is a biopharmaceutical company pioneering the application of artificial intelligence and big data analytics integrated with drug development expertise. We use our proprietary platforms to advance the next wave of medicines and significantly improve the clinical and regulatory success of drug development.
Our goal is to develop innovative medicines in immuno-oncology, neuroscience, and rare diseases with high unmet need. We believe that our Research & Development Engine can result in a disruptive change that will impact pharma productivity and innovation to benefit the entire healthcare ecosystem.
TechnologiesAI Companies (Drug Discovery)
Posts Mentioning This Company
Find applications for existing approved drugs or clinically validated candidates. Allows researchers to: Develop a pipeline of product candidates in immuno-oncology, neuroscience, and rare diseases.
No pipelines published yet
No services posted yet